| Mr Jason J Scibor, MS, LAT, ATC | |
|
1120 Se Cary Pkwy Ste 101, Cary, NC 27518-7413 | |
| (919) 467-7801 | |
| Not Available |
| Full Name | Mr Jason J Scibor |
|---|---|
| Gender | Male |
| Speciality | Specialist/technologist - Athletic Trainer |
| Location | 1120 Se Cary Pkwy Ste 101, Cary, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770152688 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0005X | Orthopaedic Surgery - Sports Medicine | 0022 (North Carolina) | Secondary |
| 2255A2300X | Specialist/technologist - Athletic Trainer | 0022 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Jason J Scibor, MS, LAT, ATC 1120 Se Cary Pkwy Ste 101, Cary, NC 27518-7413 Ph: (919) 467-7801 | Mr Jason J Scibor, MS, LAT, ATC 1120 Se Cary Pkwy Ste 101, Cary, NC 27518-7413 Ph: (919) 467-7801 |
News Archive
WaferGen Biosystems, Inc. a leading developer of state-of-the-art genomic analysis systems, today announced that it is offering an early access program for high-throughput Single Nucleotide Polymorphism Genotyping through its new SmartChip Real-Time PCR System.
Locally advanced breast cancer patients who received the same class of neoadjuvant chemotherapy were found to have no evidence of disease at the time of their surgery, or achieved pathological complete response, at the same rate regardless of race, according to researchers at The University of Texas M. D. Anderson Cancer Center.
A Wayne State University professor recently received a nearly $1.7 million grant from the National Institutes of Drug Abuse of the National Institutes of Health to explore whether proteasome and parkin — two components of the ubiquitin-proteasome system — are potential pharmaceutical drug targets that can be manipulated to promote survival and recovery of dopaminergic terminals after binge and chronic administration of toxic doses of methamphetamine.
Using a bronchoscope to visually examine the airways and collect fluid and tissue can help guide effective therapy for difficult-to-treat asthma patients, according to researchers at National Jewish Health.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a biological therapy with a mechanism of action other than tumor necrosis factor alpha (TNF-alpha) inhibition for the treatment of moderate to severe ulcerative colitis, would earn a 25 percent patient share according to surveyed U.S. gastroenterologists. Similarly, in Europe, such an agent would also earn 25 percent patient share according to surveyed European gastroenterologists.
› Verified 1 days ago